Direkt zum Inhalt
Merck

Synthesis of sydnone substituted Biginelli derivatives as hyaluronidase inhibitors.

Archiv der Pharmazie (2013-08-03)
Tegginamath Gireesh, Ravindra R Kamble, Pramod P Kattimani, Atukuri Dorababu, Maraswamy Manikantha, Joy H Hoskeri
ZUSAMMENFASSUNG

A novel series of Biginelli 2-3 (a and b) and Biginelli-like compounds 4-7 (a and b) were synthesized from 3-aryl-4-formylsydnone 1 (a and b). Since the crystal structure of hyaluronidase was unavailable, the human hyaluronidase protein structure was used as template and homology modeling was performed, validated by Ramachandran plots and subjected to docking studies along with in vitro anti-inflammatory activity assessment against hyaluronidase. Compounds 2-3 (a and b) exhibited potent enzyme inhibition.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Hyaluronidase aus Rindertestes, Type I-S, lyophilized powder, 400-1000 units/mg solid
Sigma-Aldrich
Hyaluronidase aus Rindertestes, Type IV-S, lyophilized powder (essentially salt-free), 750-3000 units/mg solid
Sigma-Aldrich
Hyaluronidase aus Rindertestes, Type IV-S, powder, suitable for mouse embryo cell culture, 750-3000 units/mg solid
Sigma-Aldrich
Hyaluronidase aus Schaftestes, Type V, lyophilized powder, ≥1,500 units/mg solid
Sigma-Aldrich
Hyaluronidase aus Rindertestes, Type VIII, lyophilized powder, 300-1,000 U/mg
Sigma-Aldrich
Hyaluronidase aus Schaftestes, Type II, lyophilized powder, ≥300 units/mg solid
Sigma-Aldrich
Hyaluronidase aus Rindertestes, Type VI-S, lyophilized powder, 3,000-15,000 units/mg solid